Inhibitory effects of retinoic acid metabolism blocking agents (RAMBAs) on the growth of human prostate cancer cells and LNCaP prostate tumour xenografts in SCID mice

por Huynh, C K, Brodie, A M H, Njar, V C O
Publicado 2006

Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR

por Schayowitz, A, Sabnis, G, Goloubeva, O, Njar, V C O, Brodie, A M H
Publicado 2010

Anti-tumour effects and pharmacokinetic profile of 17-(5′ -isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: an inhibitor of androgen synthesis

por Nnane, I P, Long, B J, Ling, Y-Z, Grigoryev, D N, Brodie, A M
Publicado 2000

Effects of new 17α-hydroxylase/C(17,20)-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo

por Grigoryev, D N, Long, B J, Nnane, I P, Njar, V C O, Liu, Y, Brodie, A M H
Publicado 1999

Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth

por Patel, J B, Mehta, J, Belosay, A, Sabnis, G, Khandelwal, A, Brodie, A M H, Soprano, D R, Njar, V C O
Publicado 2007